StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MeiraGTx's operating cash flow for the twelve months ending Jun 30, 2026 was $13.69M. For fiscal 2025 it was -$46.36M. The highest annual figure on record is $20.04M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$46.36M–
FY2024Dec 31, 2024-$104.50M–
FY2023Dec 31, 2023-$105.37M–
FY2022Dec 31, 2022-$73.10M–
FY2021Dec 31, 2021-$10.53M–
FY2020Dec 31, 2020-$63.97M-419.1%
FY2019Dec 31, 2019$20.04M–
FY2018Dec 31, 2018-$58.89M–
FY2017Dec 31, 2017-$18.06M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$38.54M–
Q1 FY2026Mar 31, 2026$17.81M–
Q4 FY2025Dec 31, 2025$46.63M–
Q3 FY2025Sep 30, 2025-$12.22M–
Q2 FY2025Jun 30, 2025-$43.95M–
Q1 FY2025Mar 31, 2025-$36.83M–
Q4 FY2024Dec 31, 2024-$23.28M–
Q3 FY2024Sep 30, 2024-$25.02M–
Q2 FY2024Jun 30, 2024-$19.46M–
Q1 FY2024Mar 31, 2024-$36.74M–
Q4 FY2023Dec 31, 2023-$14.55M–
Q3 FY2023Sep 30, 2023-$24.41M–
Q2 FY2023Jun 30, 2023-$29.01M–
Q1 FY2023Mar 31, 2023-$37.39M–
Q4 FY2022Dec 31, 2022-$16.27M-186.4%
Q3 FY2022Sep 30, 2022-$20.73M–
Q2 FY2022Jun 30, 2022-$27.81M–
Q1 FY2022Mar 31, 2022-$8.30M-191.3%
Q4 FY2021Dec 31, 2021$18.83M–
Q3 FY2021Sep 30, 2021-$17.18M–
Q2 FY2021Jun 30, 2021-$21.26M–
Q1 FY2021Mar 31, 2021$9.09M–
Q4 FY2020Dec 31, 2020-$29.56M–
Q3 FY2020Sep 30, 2020-$9.14M–
Q2 FY2020Jun 30, 2020-$12.88M–
Q1 FY2020Mar 31, 2020-$12.38M-115.1%
Q4 FY2019Dec 31, 2019-$21.97M–
Q3 FY2019Sep 30, 2019-$18.41M–
Q2 FY2019Jun 30, 2019-$21.74M–
Q1 FY2019Mar 31, 2019$82.17M–
Q4 FY2018Dec 31, 2018-$11.47M–
Q3 FY2018Sep 30, 2018-$10.99M–
Q2 FY2018Jun 30, 2018-$19.03M–
Q1 FY2018Mar 31, 2018-$17.40M–
Q4 FY2017Dec 31, 2017-$3.71M–
Q3 FY2017Sep 30, 2017-$3.82M–

More MeiraGTx figures

See a number that looks wrong?